SG Americas Securities’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-31,051
| Closed | -$637K | – | 3119 |
|
|
2024
Q2 | $637K | Buy |
+31,051
| New | +$637K | ﹤0.01% | 1409 |
|
|
2024
Q1 | – | Sell |
-29,169
| Closed | -$630K | – | 2971 |
|
|
2023
Q4 | $630K | Buy |
29,169
+19,328
| +196% | +$417K | 0.01% | 1189 |
|
|
2023
Q3 | $143K | Buy |
+9,841
| New | +$143K | ﹤0.01% | 2303 |
|
|
2023
Q2 | – | Sell |
-90,137
| Closed | -$1.9M | – | 2729 |
|
|
2023
Q1 | $1.9M | Buy |
90,137
+83,238
| +1,207% | +$1.76M | 0.02% | 625 |
|
|
2022
Q4 | $176K | Sell |
6,899
-15,967
| -70% | -$407K | ﹤0.01% | 2080 |
|
|
2022
Q3 | $549K | Sell |
22,866
-6,441
| -22% | -$155K | 0.01% | 1290 |
|
|
2022
Q2 | $564K | Buy |
29,307
+4,808
| +20% | +$92.5K | 0.01% | 1691 |
|
|
2022
Q1 | $426K | Buy |
24,499
+18,975
| +344% | +$330K | ﹤0.01% | 1775 |
|
|
2021
Q4 | $121K | Sell |
5,524
-22,726
| -80% | -$498K | ﹤0.01% | 2675 |
|
|
2021
Q3 | $540K | Buy |
+28,250
| New | +$540K | ﹤0.01% | 2226 |
|
|
2021
Q2 | – | Sell |
-7,832
| Closed | -$175K | – | 2823 |
|
|
2021
Q1 | $175K | Buy |
7,832
+3,023
| +63% | +$67.5K | ﹤0.01% | 2516 |
|
|
2020
Q4 | $107K | Buy |
+4,809
| New | +$107K | ﹤0.01% | 2647 |
|
|
2020
Q3 | – | Sell |
-14,812
| Closed | -$220K | – | 2825 |
|
|
2020
Q2 | $220K | Buy |
+14,812
| New | +$220K | ﹤0.01% | 2397 |
|
|
2019
Q2 | – | Sell |
-10,558
| Closed | -$55K | – | 2819 |
|
|
2019
Q1 | $55K | Buy |
+10,558
| New | +$55K | ﹤0.01% | 2743 |
|